BioSpace News Archive

Biotech Beach

Alexandria Venture Investments Recognized as #1 Most Active Investor in Healthcare Startups

Alexandria Venture Investments’ strategic venture activity provides the company with mission-critical data and insights as a crucial cornerstone of its unique life science business strategy

January 7, 2019
·
5 min read
Drug Development

Sage Therapeutics Announces SAGE-217 Meets Primary and Secondary Endpoints in Phase 3 Clinical Trial in Postpartum Depression

Statistically significant reduction observed in depressive symptoms compared to placebo in women with postpartum depression (PPD)

January 7, 2019
·
9 min read
Biotech Beach

Harebrained Approach To Treating Depression With Horse Tranquilizer Turns 10 Years Old

When psychiatrist David Feifel established the first program using the anesthetic drug ketamine to treat patients with depression, many considered it a harebrained idea. Today ketamine is considered the biggest psychiatric breakthrough in 50 years.

January 7, 2019
·
4 min read
Deals

Lilly Announces Agreement To Acquire Loxo Oncology

Acquisition will broaden the scope of Lilly’s oncology portfolio into precision medicines through the addition of a marketed therapy and a pipeline of highly selective potential medicines for patients with genomically defined cancers.

January 7, 2019
·
15 min read
BioMidwest

Hill-Rom Introduces LINQ™ Mobile Application

New smartphone application expands breadth of company’s digital communications portfolio

January 7, 2019
·
2 min read
Business

AGC Biologics Announces Change in Executive Leadership

Mark Womack to Succeed Robert Broeze, PhD as Chief Business Officer of AGC Biologics

January 7, 2019
·
2 min read
Pharm Country

WindRose Health Investors Closes Fund V at $705 Million

WindRose Health Investors, LLC has closed its fifth fund, WindRose Health Investors V, L.P. (“Fund V”) with $705 million in limited partner and general partner commitments. The fund was over-subscribed and closed at its fundraising cap.

January 7, 2019
·
1 min read
Business

Protagonist Therapeutics Appoints Suneel K. Gupta, Ph.D., as Executive Vice President of Clinical Operations and Pharmacology

Protagonist Therapeutics, Inc. announced the appointment of Suneel Gupta, Ph.D., as Executive Vice President of Clinical Operations and Clinical Pharmacology

January 7, 2019
·
4 min read
Business

Cardiovascular Systems, Inc. Announces Preliminary Fiscal 2019 Second-Quarter Revenues of $60.2 Million

Company Narrows Fiscal 2019 Revenue Guidance to a Range of $243 million to $247 million

January 7, 2019
·
6 min read
Business

CANbridge Pharmaceuticals and GC Pharma Announce Greater China Licensing Agreement for Hunterase™ for Hunter Syndrome

CANbridge Pharmaceuticals Inc. announced an exclusive licensing agreement in the greater China area to commercialize Hunterase™, a human recombinant iduronate-2-sulfatase (IDS) enzyme replacement therapy for the treatment of Hunter syndrome.

January 7, 2019
·
3 min read